NCT03537547 is a Phase 4 clinical trial of GeneSight Psychotropic test in Major Depressive Disorder, sponsored by Washington University School of Medicine.

Who is sponsoring NCT03537547?

NCT03537547 is sponsored by Washington University School of Medicine.

What drugs are being tested in NCT03537547?

Interventions in NCT03537547: GeneSight Psychotropic test, FDA-approved antidepressant or antipsychotic treatment.

What condition does NCT03537547 study?

NCT03537547 studies Major Depressive Disorder, Depression, Depressive Disorder, Depressive Episode, Depression, Unipolar.

Is NCT03537547 still recruiting?

NCT03537547 is currently terminated. Last updated 5 June 2020.

Last reviewed 2020-06-05 · How we verify

NCT03537547

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Combinatorial Pharmacogenomics Testing in Treatment-Naïve Major Depressive Disorder

Terminated Phase 4 Last updated 5 June 2020

What this trial tests

Phase 4 trial testing GeneSight Psychotropic test in Major Depressive Disorder in 6 participants. Terminated before completion.

Timeline

4 May 2018

Primary endpoint
19 August 2019

19 August 2019

Quick facts

Lead sponsor	Washington University School of Medicine
Phase	Phase 4
Status	Terminated
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	6
Start date	4 May 2018
Primary completion	19 August 2019
Estimated completion	19 August 2019
Sites	1 location across United States

Drugs / interventions tested

GeneSight Psychotropic test
FDA-approved antidepressant or antipsychotic treatment — full drug profile →

Conditions studied

Major Depressive Disorder — all drugs for Major Depressive Disorder →
Depression — all drugs for Depression →
Depressive Disorder — all drugs for Depressive Disorder →
Depressive Episode — all drugs for Depressive Episode →

Sponsor

Washington University School of Medicine

Who can join

Adults 18 to 65, any sex, with Major Depressive Disorder or Depression. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to determine whether the GeneSight Psychotropic test can result in better treatment outcomes for patients with treatment-naive major depressive disorder

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of GeneSight Psychotropic test

Trials testing the same drug.

NCT03749629 — Comparative Effectiveness of Pharmacogenomics for Treatment of Depression · NA · completed

Other recruiting trials for Major Depressive Disorder

Currently open trials in the same condition.

NCT07219394 — Peer-Delivered Behavioral Activation in a CCBHC · NA · recruiting
NCT06705478 — Pramipexole Versus Escitalopram to Treat Major Depressive Disorder (MDD) and Comorbid MDD With Mild Neurocognitive Disor · Phase 2 · recruiting
NCT06749392 — An Individual-specific Synchrony Signature · NA · recruiting
NCT07316803 — Group Intervention for Romantic Relationships in Young Adults With Severe Mental Illness · NA · recruiting
NCT07242105 — Optimizing Brain Excitability in Depression · NA · recruiting

Other Washington University School of Medicine trials

Trials by the same sponsor.

NCT05521997 — Glutaminase Inhibition and Chemoradiation in Advanced Cervical Cancer · Phase 2 · not yet recruiting
NCT07101666 — Total Neoadjuvant Therapy With Short Course Radiation Therapy in Gastric Cancer · Phase 2 · not yet recruiting
NCT07200089 — Recombinant Human IL-7 (NT-I7) in Relapsed/Refractory Multiple Myeloma Following BCMA CAR-T Therapy (Cilta-cel) · Phase 1 · not yet recruiting
NCT07313592 — Whole Genome Sequencing (ChromoSeq®) for Acute Lymphoblastic Leukemia (ALL) Patients · not yet recruiting
NCT07419464 — 5-Fluorouracil Response and Optimization STudy (The FROST Trial) · Phase 2 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03537547 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Washington University School of Medicine
Last refreshed: 5 June 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03537547.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing